An experiment involving women with major depressive disorder found improvements in their quality of life, emotion regulation ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Double depression combines long-term dysthymia with major depressive episodes, causing persistent sadness, fatigue, and ...

Discover the overlooked mental health condition of dysthymia through Baek Sehee's therapy memoir, sparking an important ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.

Biological markers, such as hormone levels or neuroimaging findings, are a potential way to predict manic or depressive ...